Oral and nasal vaccination: current prospects, challenges, and impact of nanotechnology-based delivery systems

Autor(es)

Natália Floriano Paiva ^[1] ; Fabiana Testa Moura de Carvalho Vicentini ^[2]

Afiliação do(s) autor(es)

^[1] University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto - Brasil

^[2] University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto - Brasil

• Tipo de documento: Artigo Científico
• Fonte: Brazilian Journal of Pharmaceutical Sciences; v. 59, 2023-05-08.

Resumo

Abstract Currently, mucosal vaccine administration has stood out as an easier and non-invasive application method. It can also be used to induce local and systemic immune responses. In the COVID-19 pandemic context, nasal and oral vaccines have been developed based on different technological platforms. This review addressed relevant aspects of mucosal vaccine administration, with emphasis on oral and nasal vaccinations, in addition to the importance of using nanotechnology-based delivery systems to enable these strategies. (AU)

• Processo FAPESP: 19/08891-8 - Uso de nanopartículas de ferritina como base para o desenvolvimento de sistemas de liberação de vacina antitumoral
• Beneficiário: Fabiana Testa Moura de Carvalho Vicentini
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 19/25548-5 - Desenvolvimento e caracterização de nanopartículas de ferritina para veiculação de uma vacina de DNA
• Beneficiário: Natália Floriano Paiva
• Modalidade de apoio: Bolsas no Brasil - Iniciação Científica